Search research articles
Contact Us
Filters
Showing results (51-60 of 117) with videos related to
Page
of 12
Sort By:
Cancer Research
|
October 11, 2017
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer
Purushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, et al.
Gynecologic Oncology
|
January 3, 2021
Image-guided tumor ablation in gynecologic oncology: Review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program
Michael R Moynagh, Sean C Dowdy, Brian Welch, et al.
Journal of Surgical Oncology
|
February 22, 2021
Clinical significance of SLN benign capsular nevi in patients with melanoma
Thomas S Yamashita, Barbara A Pockaj, Sanjay P Bagaria, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
October 27, 2021
<i>BRAF</i> V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)
Jessica A Slostad, Minetta C Liu, Jacob B Allred, et al.
Anticancer Research
|
July 3, 2017
Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer
Amanika Kumar, Michelle L Torres, William A Cliby, et al.
Melanoma Research
|
March 16, 2017
Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma
Roberto A Leon-Ferre, Lisa A Kottschade, Matthew S Block, et al.
The British Journal of Surgery
|
November 4, 2024
Neoadjuvant immunotherapy versus adjuvant chemotherapy in anorectal melanoma
Richard Sassun, Annaclara Sileo, Jyi Cheng Ng, et al.
Gynecologic Oncology
|
July 13, 2023
Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Anousheh Shafa, A Brooke Watkins, Michaela E McGree, et al.
Melanoma Research
|
August 29, 2024
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting
Ronen Stoff, Svetomir N Markovic, Robert R McWilliams, et al.
Oncoimmunology
|
June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
Yingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 117) with videos related to
Sort By:
Page
of 12
Cancer Research
|
October 11, 2017
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer
Purushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, et al.
Gynecologic Oncology
|
January 3, 2021
Image-guided tumor ablation in gynecologic oncology: Review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program
Michael R Moynagh, Sean C Dowdy, Brian Welch, et al.
Journal of Surgical Oncology
|
February 22, 2021
Clinical significance of SLN benign capsular nevi in patients with melanoma
Thomas S Yamashita, Barbara A Pockaj, Sanjay P Bagaria, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
October 27, 2021
<i>BRAF</i> V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)
Jessica A Slostad, Minetta C Liu, Jacob B Allred, et al.
Anticancer Research
|
July 3, 2017
Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer
Amanika Kumar, Michelle L Torres, William A Cliby, et al.
Melanoma Research
|
March 16, 2017
Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma
Roberto A Leon-Ferre, Lisa A Kottschade, Matthew S Block, et al.
The British Journal of Surgery
|
November 4, 2024
Neoadjuvant immunotherapy versus adjuvant chemotherapy in anorectal melanoma
Richard Sassun, Annaclara Sileo, Jyi Cheng Ng, et al.
Gynecologic Oncology
|
July 13, 2023
Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Anousheh Shafa, A Brooke Watkins, Michaela E McGree, et al.
Melanoma Research
|
August 29, 2024
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting
Ronen Stoff, Svetomir N Markovic, Robert R McWilliams, et al.
Oncoimmunology
|
June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
Yingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Page
of 12